A Johns Hopkins Armstrong Institute for Patient Safety and Quality program cut hospital-onset bloodstream infections caused by methicillin-resistant Staphylococcus aureus by 65%.
The study, published Aug. 27 in JAMA Network Open, implemented the Agency for Healthcare Research and Quality Safety Program for MRSA Prevention across 106 ICUs and 87 non-ICUs at 94 hospitals across the U.S. In the study, the 18-month program helped healthcare teams consistently implement comprehensive infection prevention strategies targeting MRSA transmission and infection. Units received education and resources on hand hygiene, environmental cleaning, device-associated infection prevention, chlorhexidine bathing and nasal decolonization, according to a Sept. 14 hospital news release.
Researchers compared infection rates during the 18-month program to the previous 12 months and found:
1. The rate of hospital-onset MRSA bloodstream infections dropped 65% during the implementation period.
2. There was a 39% reduction in MRSA-positive clinical cultures collected later during hospitalization.
3. Researchers found a 37% cut in bloodstream infections from all causes and a 31% reduction in central line-associated bloodstream infections.
4. The proportion of units reporting nasal MRSA decolonization for all patients increased from 35% to 61% for ICUs and 13% to 35% for non-ICUs.
5. Monitoring of environmental cleaning also increased from 50% to 75% in ICUs and from 52% to 76% among non-ICUs.
The AHRQ MRSA Prevention Toolkit can be found here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
